Cantor Fitzgerald Reiterates Overweight on Zura Bio
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Josh Schimmer has reiterated an Overweight rating on Zura Bio (NASDAQ:ZURA).

June 17, 2024 | 1:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Josh Schimmer has reiterated an Overweight rating on Zura Bio, indicating a positive outlook for the stock.
The reiteration of an Overweight rating by a reputable analyst suggests confidence in Zura Bio's future performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100